State University of New York, Downstate Medical Center, Brooklyn, New York, USA.
Otolaryngol Head Neck Surg. 2021 Mar;164(3):489-500. doi: 10.1177/0194599820947742. Epub 2020 Aug 18.
Endoscopic surgical management or injection laryngoplasty of type 1 laryngeal clefts in pediatric patients is used in those who do not respond to conservative treatment. This study compares conservative treatment, endoscopic surgical repair, and injection laryngoplasty for the management of type 1 laryngeal clefts.
PubMed, Web of Science, and Embase.
This systematic review included studies of patients with type 1 laryngeal clefts who were managed with conservative treatment, injection laryngoplasty, or endoscopic repair, and all studies reported postintervention outcomes. Two independent investigators assessed study eligibility, rated the quality, and extracted data for analysis. A random effects model was used for meta-analysis of pooled data.
Of the 1209 studies identified, 27 met inclusion criteria. There were 543 patients with type 1 laryngeal clefts represented in the studies, with outcomes reported for 537. Conservative therapy had a 52% (95% CI, 37%-66%; = 63%) success rate at improving symptoms, while endoscopic repair had a significantly higher percentage resolution of symptoms (70%; 95% CI, 59%-79%; = 62%, < .001) as compared with conservative treatment (51%; 95% CI, 36%-65%; = 62%) or injection laryngoplasty (36%; 95% CI, 20%-57%; = 70%). The quality scores of the studies ranged from 7 to 12 out of 16.
Our systematic review demonstrated significant improvement and resolution of symptoms for patients with type 1 laryngeal clefts treated with endoscopic repair as compared with other modalities. More prospective and controlled studies comparing treatment strategies with validated instruments to measure outcomes are necessary to determine their efficacy in the management of type 1 laryngeal clefts.
对于保守治疗无效的 1 型喉裂患儿,采用内镜手术治疗或注射性喉成形术。本研究比较了保守治疗、内镜修复和注射性喉成形术治疗 1 型喉裂的效果。
PubMed、Web of Science 和 Embase。
本系统评价纳入了接受保守治疗、注射性喉成形术或内镜修复治疗的 1 型喉裂患者的研究,并报告了所有干预后的结果。两名独立的研究者评估了研究的入选标准、质量评分,并提取数据进行分析。采用随机效应模型对汇总数据进行荟萃分析。
在 1209 项研究中,有 27 项符合纳入标准。研究中共有 543 例 1 型喉裂患者,其中 537 例患者的结局得到了报告。保守治疗改善症状的成功率为 52%(95%CI,37%-66%; = 63%),而内镜修复的症状缓解率显著高于保守治疗(70%,95%CI,59%-79%; = 62%,<.001)或注射性喉成形术(36%,95%CI,20%-57%; = 70%)。研究的质量评分范围为 16 分中的 7 分至 12 分。
本系统评价显示,与其他治疗方法相比,内镜修复治疗 1 型喉裂患者的症状显著改善和缓解。需要更多前瞻性、对照研究,并采用验证有效的工具来测量结局,以确定这些治疗策略在治疗 1 型喉裂中的疗效。